Phase three trials for a drug which targets Alzheimer’s disease developed by a company spun out of the University of Aberdeen have shown promising results.
from Dementia Big http://ift.tt/2ae7grh via alcoholic dementia
http://ift.tt/2acdCn6
Thursday, July 28, 2016
Promising drug trials for spin-out company in the fight against Alzheimer's disease
http://ift.tt/2acdCn6
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment